CXCR4 antagonists for treatment of breast cancer

Oncotarget. 2018 Sep 11;9(71):33442-33443. doi: 10.18632/oncotarget.26090.
No abstract available

Keywords: CXCR4 antagonists; balixafortide; breast cancer; eribulin; oncology.

Publication types

  • Editorial